Strategic partnerships Affiliation with University of Basel and Novartis Institutes for BioMedical Research suggests open channels for collaborative grant-funded projects, joint research opportunities, and access to academic and industry networks for co-development and sponsored studies.

Human capital A diverse international team with 19 research groups and a broad focus on neurobiology, genome regulation, and multicellular systems indicates potential for cross-disciplinary collaborations, contract research, and expert consultation services to accelerate partner R&D objectives.

Tech enabled Adoption of cloud and enterprise tech (AWS, Microsoft 365, Adobe Experience Cloud, Airtable) signals readiness for data management, collaboration platforms, and scalable digital infrastructure that can support partner-driven data projects, dashboards, and secure information sharing.

Funding signals Reported revenue range and a compact institute size imply opportunities for targeted funding proposals, sponsored research, and philanthropy-driven collaborations with mid-market biotech firms seeking academic rigor without large-scale overhead.

Research footprint Active research in chromatin proteomics and transcriptional regulation, plus notable collaborations in Hydra biology, highlights niche capabilities that can be marketed to biotech and pharma clients seeking specialized assay development, mass spectrometry workflows, and advanced proteomics services.